Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP)
Keyword(s):
2014 ◽
Vol 23
(2)
◽
pp. 301-302
◽
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 56
(5)
◽
pp. 1510-1513
◽
Keyword(s):